CD133+ and CD133- Cancer stem cells in glioblastoma

被引：0
|
作者：
Beier, D.
Hau, P.
Proescholdt, M.
Lohmeier, A.
Aigner, L.
Brawanski, A.
Bogdahn, U.
Beier, C. P.
机构：
[1] Dept Neurol, Regensburg, Germany
[2] Dept Neurosurg, Regensburg, Germany
来源：
NEURO-ONCOLOGY | 2006年 / 8卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：317 / 317
页数：1
相关论文
共 50 条
  • [1] Differential characteristics of CD133+ and CD133- Jurkat cells
    Anbarlou, Azadeh
    Atashi, Amir
    Soleimani, Masoud
    AkhavanRahnama, Mahshid
    Bohloli, Mahbobeh
    Mossahebi-Mohammadi, Majid
    IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL, 2015, 51 (06) : 556 - 561
  • [2] CD133+ and CD133- glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles
    Beier, Dagmar
    Hau, Peter
    Proescholdt, Martin
    Lohmeier, Annette
    Wischhusen, Joerg
    Oefner, Peter J.
    Aigner, Ludwig
    Brawanski, Alexander
    Bogdahn, Ulrich
    Beier, Christoph P.
    CANCER RESEARCH, 2007, 67 (09) : 4010 - 4015
  • [3] CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors
    Shmelkov, Sergey V.
    Butler, Jason M.
    Hooper, Andrea T.
    Hormigo, Adilia
    Kushner, Jared
    Milde, Till
    St. Clair, Ryan
    Baljevic, Muhamed
    White, Ian
    Jin, David K.
    Chadburn, Amy
    Murphy, Andrew J.
    Valenzuela, David M.
    Gale, Nicholas W.
    Thurston, Gavin
    Yancopoulos, George D.
    D'Angelica, Michael
    Kemeny, Nancy
    Lyden, David
    Rafii, Shahin
    JOURNAL OF CLINICAL INVESTIGATION, 2008, 118 (06): : 2111 - 2120
  • [4] Transcriptional Profiles of CD133+ and CD133- Glioblastoma-Derived Cancer Stem Cell Lines Suggest Different Cells of Origin
    Lottaz, Claudio
    Beier, Dagmar
    Meyer, Katharina
    Kumar, Praveen
    Hermann, Andreas
    Schwarz, Johannes
    Junker, Markus
    Oefner, Peter J.
    Bogdahn, Ulrich
    Wischhusen, Joerg
    Spang, Rainer
    Storch, Alexander
    Beier, Christoph P.
    CANCER RESEARCH, 2010, 70 (05) : 2030 - 2040
  • [5] Transforming growth factor-β mimics the key proteome properties of CD133- differentiated and CD133+ cancer stem cells in glioblastoma
    Bryukhovetskiy, Igor
    Shevchenko, Valeriy
    Arnotskaya, Natalia
    Kushnir, Tatyana
    Pak, Oleg
    Victor, Zgoda
    Zaitsev, Sergei
    Khotimchenko, Yuri
    Bryukhovetskiy, Andrey
    Sharma, Aruna
    Sharma, Hari Shanker
    NOVEL THERAPEUTIC ADVANCES IN GLIOBLASTOMA, 2020, 151 : 219 - 242
  • [6] Hexokinase II in CD133+ and CD133- Hepatoma BEL-7402 Cells
    Gong, Lei
    Cui, Zhuqingqing
    Yu, Xin
    Wei, Yuhua
    Peng, Jirun
    Leng, Xisheng
    PATHOLOGY & ONCOLOGY RESEARCH, 2012, 18 (02) : 377 - 381
  • [7] Expression profiling of CD133+ and CD133- epithelial cells from human prostate
    Shepherd, Christopher J.
    Rizzo, Sian
    Ledaki, Ioanna
    Davies, Melissa
    Brewer, Daniel
    Attard, Gerhardt
    de Bono, Johann
    Hudson, David L.
    PROSTATE, 2008, 68 (09): : 1007 - 1024
  • [8] Daoy medulloblastoma cells that express CD133 are radioresistant relative to CD133- cells, and the CD133+ sector is enlarged by hypoxia
    Blazek, Ed R.
    Foutch, Jennifer L.
    Maki, Guitta
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 67 (01): : 1 - 5
  • [9] Iterative sorting reveals CD133+ and CD133- melanoma cells as phenotypically distinct populations
    Carole Grasso
    Matthew Anaka
    Oliver Hofmann
    Ramakrishna Sompallae
    Kate Broadley
    Winston Hide
    Michael V. Berridge
    Jonathan Cebon
    Andreas Behren
    Melanie J. McConnell
    BMC Cancer, 16
  • [10] CD133+ cancer stem cells in lung cancer
    Wang, Shuang
    Xu, Zhen Ye
    Wang, Li Fang
    Su, Wan
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2013, 18 : 447 - 453
12345